The trademark ENKARLYS was filed by Sage Therapeutics, Inc., a U.S. corporation (the "Applicant"). The application was published for oppositions on July 13, 2020, and received one opposition filed on October 5, 2020 by CHIESI FARMACEUTICI S.P.A. on Likelihood of confusion. the opponent was represented by GIAMBROCONO & C. S.P.A. and proceedings were handled in English, and the oppositon was dismissed by the Euorpean Union Intellectual Property Office with decision issued October 5, 2020
The application was filed in English, and English was also language of all opposition proceedings (German was selected as the second language).
The Opposition with reference B 003132160 was refused according to Article 8(1)(b) EUTMR with decision issued on August 24, 2022 by the EUIPO.